CD69 and regulation of the immune function.

CD69, also known as activation inducer molecule, very early activation antigen, MLR-3 and Leu-23, is a member of the natural killer (NK) cell gene complex family of signal transducing receptors. CD69 is as a type II transmembrane glycoprotein with a C-type lectin binding domain in the extracellular portion of the molecule. CD69 expression is induced in vitro on cells of most hematopoietic lineages, including T and B lymphocytes, NK cells, murine macrophages, neutrophils and eosinophils, while it is constitutively expressed on human monocytes, platelets and epidermal Langerhans cells. Although a specific ligand for CD69 has not been identified, its wide cellular distribution and the induction of intracellular signals upon CD69 crosslinking suggest a role for the receptor in the biology of hematopoietic cells. Moreover, certain results indicate that CD69 may be involved in the pathogenesis of such diseases as rheumatoid arthritis, chronic inflammatory liver diseases, mild asthma, and acquired immunodeficiency syndrome.

[1]  D. Ikle,et al.  Early preferential stimulation of gamma delta T cells by TNF-alpha. , 1998, Journal of immunology.

[2]  L. Bonomo,et al.  Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three‐colour cytometric analysis. , 1997, International journal of experimental pathology.

[3]  E. Jirillo,et al.  Expression and function of the early activation antigen CD69 in murine macrophages , 1997, Journal of leukocyte biology.

[4]  C. De Simone,et al.  Pathogenetic role of phagocytic abnormalities in human virus immunodeficiency infection: possible therapeutical approaches. A review. , 1997, Immunopharmacology and immunotoxicology.

[5]  M. McGrath,et al.  Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.

[6]  G. Kroemer,et al.  CD69-induced monocyte apoptosis involves multiple nonredundant signaling pathways. , 1996, Cellular immunology.

[7]  F. Sánchez‐Madrid,et al.  Anti‐CD69 antibodies enhance phorbol‐dependent glucose metabolism and Ca2+ levels in human thymocytes. Antagonist effect of cyclosporin A , 1996, Journal of leukocyte biology.

[8]  F. Symon,et al.  Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. , 1996, Blood.

[9]  J. Siegel,et al.  Raf‐1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells , 1995, European journal of immunology.

[10]  P. Debré,et al.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Vandekerckhove,et al.  Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. , 1995, Journal of immunology.

[12]  R. Testi,et al.  Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors , 1994, The Journal of experimental medicine.

[13]  J. Gordon,et al.  B-cell signalling via the C-type lectins CD23 and CD72. , 1994, Immunology today.

[14]  R. Lynch,et al.  Heterogeneity and biased T cell receptor alpha/beta repertoire of mucosal CD8+ cells from murine large intestine: implications for functional state , 1994, The Journal of experimental medicine.

[15]  R. Testi,et al.  Involvement of p21ras activation in T cell CD69 expression , 1994, European journal of immunology.

[16]  S. Ziegler,et al.  The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. , 1994, Journal of immunology.

[17]  A. Wardlaw,et al.  CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. , 1993, Immunology.

[18]  G. Trinchieri,et al.  Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells. , 1993, Cellular immunology.

[19]  F. Sánchez‐Madrid,et al.  Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors , 1993, The Journal of experimental medicine.

[20]  S. Ziegler,et al.  Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens , 1993, European journal of immunology.

[21]  M. López-Botet,et al.  Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. , 1993, Chest.

[22]  M. Strauss,et al.  Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. , 1993, Journal of immunology.

[23]  W. Chambers,et al.  Type II integral membrane proteins with characteristics of C-type animal lectins expressed by natural killer (NK) cells. , 1993, Glycobiology.

[24]  N. Narita,et al.  In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. , 1992, The Journal of allergy and clinical immunology.

[25]  R. Gavioli,et al.  CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. , 1992, Cellular immunology.

[26]  R. Testi,et al.  Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation. , 1992, Journal of immunology.

[27]  F. Sánchez‐Madrid,et al.  Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathway , 1992 .

[28]  F. Sánchez‐Madrid,et al.  Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. , 1992, Journal of immunology.

[29]  E. Ciccone,et al.  CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta , 1991, The Journal of experimental medicine.

[30]  R. Giorda,et al.  Mouse NKR-P1. A family of genes selectively coexpressed in adherent lymphokine-activated killer cells. , 1991, Journal of immunology.

[31]  D. Mager,et al.  Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. , 1991, Journal of immunology.

[32]  F. Sánchez‐Madrid,et al.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. , 1991, The Journal of clinical investigation.

[33]  M. Capra,et al.  CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. , 1991, Journal of immunology.

[34]  M. Scardoni,et al.  Interferon alpha induces expression of the CD69 activation antigen in human resting NK cells, while interferon gamma and tumor necrosis factor alpha are ineffective. , 1991, International journal of cancer.

[35]  T. Pozzan,et al.  Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes. , 1991, Molecular immunology.

[36]  S. Nakamura,et al.  Expression of early activation antigen (CD69) during human thymic development , 1990, Clinical and experimental immunology.

[37]  R. Testi,et al.  CD69 is expressed on platelets and mediates platelet activation and aggregation , 1990, The Journal of experimental medicine.

[38]  F. Sánchez‐Madrid,et al.  Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. , 1990, Gastroenterology.

[39]  E. Ciccone,et al.  CD 16 surface molecules regulate the cytolytic function of CD3−CD16+ human natural killer cells , 1989 .

[40]  R. Testi,et al.  T cell activation via Leu-23 (CD69). , 1989, Journal of immunology.

[41]  R. Testi,et al.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. , 1989, Journal of immunology.

[42]  A. Rubartelli,et al.  MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors , 1989, European journal of immunology.

[43]  S. Nakamura,et al.  The 28-kDa/32-kDa activation antigen EA 1. Further characterization and signal requirements for its expression. , 1988, Journal of immunology.

[44]  F. Sánchez‐Madrid,et al.  Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes , 1988, The Journal of experimental medicine.

[45]  R. Testi,et al.  Constitutive expression of a phosphorylated activation antigen (Leu 23) by CD3bright human thymocytes. , 1988, Journal of Immunology.

[46]  K. Drickamer,et al.  Two distinct classes of carbohydrate-recognition domains in animal lectins. , 1988, The Journal of biological chemistry.

[47]  J. Coligan,et al.  Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. , 1988, Journal of immunology.

[48]  L. Lanier,et al.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen , 1988, The Journal of experimental medicine.

[49]  G. Trinchieri,et al.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.

[50]  B. Ferruà,et al.  Inhibition and activation of interleukin 2 synthesis by direct modification of guanosine triphosphate-binding proteins. , 1988, Journal of immunology.

[51]  F. Cozzolino,et al.  Functional characterization of an antigen involved in an early step of T-cell activation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Stoter,et al.  Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. , 1987, Journal of immunology.

[53]  S. Fu,et al.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o- tetradecanoyl phorbol-13-acetate, mitogens, and antigens , 1986, The Journal of experimental medicine.

[54]  D. Shoback,et al.  Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium. , 1986, Proceedings of the National Academy of Sciences of the United States of America.